fenfluramine oral solution
fenfluramine) oral solution, CIV
Initial U.S. Approval: 1973
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older
Facts about fenfluramine oral solution
Approval Date: 1973
Proprietary Name: On Request
Active Ingredient(s): fenfluramine oral solution
FDA-approved use: Lennox-Gastaut syndrome, another form of epilepsy
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA),
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “fenfluramine oral solution” based on the information you provide.
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
Query For fenfluramine oral solution
Approved accessible "fenfluramine oral solution"
Fintepla (fenfluramine) oral solution was approved in 2020 for Dravet syndrome, a type of epilepsy, in patients aged two years and older. In 2022, CDER approved Fintepla to treat Lennox-Gastaut syndrome, another form of epilepsy, in patients aged two years and older.
How can 1 go about obtaining fenfluramine oral solution?
If fenfluramine oral solution are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).
FINTEPLA (fenfluramine) oral solution, CIV Initial U.S. Approval: 1973
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Indian Pharma Network
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398